Abstract
BackgroundIn vivo quantification of spinal cord atrophy in neurological diseases using MRI has attracted increasing attention.PurposeTo compare across different platforms the most promising imaging techniques to assess human spinal cord atrophy.Study TypeTest/retest multiscanner study.SubjectsTwelve healthy volunteers.Field Strength/SequenceThree different 3T scanner platforms (Siemens, Philips, and GE) / optimized phase sensitive inversion recovery (PSIR), T1‐weighted (T1‐w), and T2*‐weighted (T2*‐w) protocols.AssessmentOn all images acquired, two operators assessed contrast‐to‐noise ratio (CNR) between gray matter (GM) and white matter (WM), and between WM and cerebrospinal fluid (CSF); one experienced operator measured total cross‐sectional area (TCA) and GM area using JIM and the Spinal Cord Toolbox (SCT).Statistical TestsCoefficient of variation (COV); intraclass correlation coefficient (ICC); mixed effect models; analysis of variance (t‐tests).ResultsFor all the scanners, GM/WM CNR was higher for PSIR than T2*‐w (P < 0.0001) and WM/CSF CNR for T1‐w was the highest (P < 0.0001). For TCA, using JIM, median COVs were smaller than 1.5% and ICC >0.95, while using SCT, median COVs were in the range 2.2–2.75% and ICC 0.79–0.95. For GM, despite some failures of the automatic segmentation, median COVs using SCT on T2*‐w were smaller than using JIM manual PSIR segmentations. In the mixed effect models, the subject was always the main contributor to the variance of area measurements and scanner often contributed to TCA variance (P < 0.05). Using JIM, TCA measurements on T2*‐w were different than on PSIR (P = 0.0021) and T1‐w (P = 0.0018), while using SCT, no notable differences were found between T1‐w and T2*‐w (P = 0.18). JIM and SCT‐derived TCA were not different on T1‐w (P = 0.66), while they were different for T2*‐w (P < 0.0001). GM area derived using SCT/T2*‐w versus JIM/PSIR were different (P < 0.0001).Data ConclusionThe present work sets reference values for the magnitude of the contribution of different effects to cord area measurement intra‐ and interscanner variability. Level of Evidence: 1 Technical Efficacy: Stage 4J. Magn. Reson. Imaging 2019;49:1078–1090.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.